EU-funded JOIN4ATMP project aims to overcome regulatory obstacles

They offer hope for people who do not respond to conventional treatments or for whom there is no effective therapy yet available: advanced therapy medicinal products (ATMPs). The first of these novel medications, developed using genetic and cell technologies, were officially approved just five years…